BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28929463)

  • 1. Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases.
    Conrad C; Vauthey JN; Masayuki O; Sheth RA; Yamashita S; Passot G; Bailey CE; Zorzi D; Kopetz S; Aloia TA; You YN
    Ann Surg Oncol; 2017 Dec; 24(13):3857-3864. PubMed ID: 28929463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival.
    Labori KJ; Guren MG; Brudvik KW; Røsok BI; Waage A; Nesbakken A; Larsen S; Dueland S; Edwin B; Bjørnbeth BA
    Colorectal Dis; 2017 Aug; 19(8):731-738. PubMed ID: 28181384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the outcome of surgery in patients with rectal cancer and synchronous liver metastases.
    van der Pool AE; de Wilt JH; Lalmahomed ZS; Eggermont AM; Ijzermans JN; Verhoef C
    Br J Surg; 2010 Mar; 97(3):383-90. PubMed ID: 20101594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological strategies for locally advanced rectal cancer with synchronous liver metastases, interval strategy versus rectum first strategy: a comparison of short-term outcomes.
    Salvador-Rosés H; López-Ben S; Casellas-Robert M; Planellas P; Gómez-Romeu N; Farrés R; Ramos E; Codina-Cazador A; Figueras J
    Clin Transl Oncol; 2018 Aug; 20(8):1018-1025. PubMed ID: 29273957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage IV rectal cancer with liver metastases: is there a benefit to resection of the primary tumor?
    Cellini C; Hunt SR; Fleshman JW; Birnbaum EH; Bierhals AJ; Mutch MG
    World J Surg; 2010 May; 34(5):1102-8. PubMed ID: 20177683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is complete liver resection without resection of synchronous lung metastases justified?
    Mise Y; Kopetz S; Mehran RJ; Aloia TA; Conrad C; Brudvik KW; Taggart MW; Vauthey JN
    Ann Surg Oncol; 2015 May; 22(5):1585-92. PubMed ID: 25373535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies for rectal cancer with synchronous liver metastases: surgical and oncological outcomes with propensity-score analysis.
    Salvador-Rosés H; López-Ben S; Planellas P; Canals E; Casellas-Robert M; Farrés R; Ramos E; Codina-Cazador A; Figueras J
    Clin Transl Oncol; 2018 Feb; 20(2):221-229. PubMed ID: 28707036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced mid/low rectal cancer with synchronous liver metastases.
    Viganò L; Karoui M; Ferrero A; Tayar C; Cherqui D; Capussotti L
    World J Surg; 2011 Dec; 35(12):2788-95. PubMed ID: 21947493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal outcomes after a liver-first treatment of patients with stage IV rectal cancer.
    Buchs NC; Ris F; Majno PE; Andres A; Cacheux W; Gervaz P; Roth AD; Terraz S; Rubbia-Brandt L; Morel P; Mentha G; Toso C
    Ann Surg Oncol; 2015 Mar; 22(3):931-7. PubMed ID: 25201505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer.
    Maki H; Ayabe RI; Nishioka Y; Konishi T; Newhook TE; Tran Cao HS; Chun YS; Tzeng CD; You YN; Vauthey JN
    Ann Surg Oncol; 2023 Sep; 30(9):5390-5400. PubMed ID: 37285096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy and primary-first approach for rectal cancer with synchronous liver metastases.
    Gall TM; Basyouny M; Frampton AE; Darzi A; Ziprin P; Dawson P; Paraskeva P; Habib NA; Spalding DR; Cleator S; Lowdell C; Jiao LR
    Colorectal Dis; 2014 Jun; 16(6):O197-205. PubMed ID: 24344746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-Term Outcomes after Simultaneous Colorectal and Major Hepatic Resection for Synchronous Colorectal Liver Metastases.
    Ono Y; Saiura A; Arita J; Takahashi Y; Takahashi M; Inoue Y
    Dig Surg; 2017; 34(6):447-454. PubMed ID: 28319941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of treatment sequence on survival in stage IV rectal cancer with synchronous and potentially resectable liver metastases.
    Ghiasloo M; Kahya H; Van Langenhove S; Grammens J; Vierstraete M; Berardi G; Troisi RI; Ceelen W
    J Surg Oncol; 2019 Sep; 120(3):415-422. PubMed ID: 31218689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome after simultaneous resection of gastric primary tumour and synchronous liver metastases: survival analysis of a single-center experience in China.
    Liu Q; Bi JJ; Tian YT; Feng Q; Zheng ZX; Wang Z
    Asian Pac J Cancer Prev; 2015; 16(4):1665-9. PubMed ID: 25743789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical resection of colorectal liver metastases: Gold standard for solitary and radically resectable lesions].
    Scheele J; Altendorf-Hofmann A; Stangl R; Schmidt K
    Swiss Surg; 1996; Suppl 4():4-17. PubMed ID: 8963836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "liver-first approach" for patients with locally advanced rectal cancer and synchronous liver metastases.
    Verhoef C; van der Pool AE; Nuyttens JJ; Planting AS; Eggermont AM; de Wilt JH
    Dis Colon Rectum; 2009 Jan; 52(1):23-30. PubMed ID: 19273952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological strategies for middle and low rectal cancer with synchronous liver metastases.
    Sabbagh C; Cosse C; Ravololoniaina T; Chauffert B; Joly JP; Mauvais F; Regimbeau JM
    Int J Surg; 2015 Nov; 23(Pt A):186-93. PubMed ID: 26316155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases.
    Cho H; Kim JE; Kim KP; Yu CS; Kim JC; Kim JH; Lee MA; Jang HS; Oh ST; Kim SY; Oh JH; Kim DY; Hong YS; Kim TW
    Am J Clin Oncol; 2016 Dec; 39(6):623-629. PubMed ID: 27322695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upfront chemotherapy and short-course radiotherapy with delayed surgery for locally advanced rectal cancer with synchronous liver metastases.
    Bae HW; Kim HS; Yang SY; Kim HS; Shin SJ; Chang JS; Koom WS; Kim NK
    Eur J Surg Oncol; 2021 Nov; 47(11):2814-2820. PubMed ID: 34024668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.